Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1357 to 56 of 56 entries
Sorted by: Best Match Show Resources per page
About ISSX.

Drug metabolism reviews

[No authors listed]
PMID: 26247903
Drug Metab Rev. 2015;47:4. doi: 10.3109/03602532.2015.1071932. Epub 2015 Oct 02.

No abstract available.

Cite
About ISSX. Drug Metab Rev. 2015;47:4doi: 10.3109/03602532.2015.1071932.
(2015). About ISSX. Drug metabolism reviews, 474. https://doi.org/10.3109/03602532.2015.1071932
"About ISSX." Drug metabolism reviews vol. 47 (2015): 4. doi: https://doi.org/10.3109/03602532.2015.1071932
About ISSX. Drug Metab Rev. 2015;47:4. doi: 10.3109/03602532.2015.1071932. Epub 2015 Oct 02. PMID: 26247903.
Copy Download .nbib Format: NLM
Erratum.

Drug metabolism reviews

[No authors listed]
PMID: 28925770
Drug Metab Rev. 2004 Feb 26;36(1):157. doi: 10.1081/DMR-120028429.

No abstract available.

Cite
Erratum. Drug Metab Rev. 2004;36(1):157doi: 10.1081/DMR-120028429.
(2004). Erratum. Drug metabolism reviews, 36(1), 157. https://doi.org/10.1081/DMR-120028429
"Erratum." Drug metabolism reviews vol. 36,1 (2004): 157. doi: https://doi.org/10.1081/DMR-120028429
Erratum. Drug Metab Rev. 2004 Feb 26;36(1):157. doi: 10.1081/DMR-120028429. PMID: 28925770.
Copy Download .nbib Format: NLM
Poster Awards Finalist Abstracts.

Drug metabolism reviews

[No authors listed]
PMID: 26430820
Drug Metab Rev. 2015;47:34-40. doi: 10.3109/03602532.2015.1071931. Epub 2015 Oct 02.

No abstract available.

Cite
Poster Awards Finalist Abstracts. Drug Metab Rev. 2015;47:34-40doi: 10.3109/03602532.2015.1071931.
(2015). Poster Awards Finalist Abstracts. Drug metabolism reviews, 4734-40. https://doi.org/10.3109/03602532.2015.1071931
"Poster Awards Finalist Abstracts." Drug metabolism reviews vol. 47 (2015): 34-40. doi: https://doi.org/10.3109/03602532.2015.1071931
Poster Awards Finalist Abstracts. Drug Metab Rev. 2015;47:34-40. doi: 10.3109/03602532.2015.1071931. Epub 2015 Oct 02. PMID: 26430820.
Copy Download .nbib Format: NLM
About ISSX.

Drug metabolism reviews

[No authors listed]
PMID: 27418300
Drug Metab Rev. 2016 Jul;48:4. doi: 10.1080/03602532.2016.1191842.

No abstract available.

Cite
About ISSX. Drug Metab Rev. 2016;48:4doi: 10.1080/03602532.2016.1191842.
(2016). About ISSX. Drug metabolism reviews, 484. https://doi.org/10.1080/03602532.2016.1191842
"About ISSX." Drug metabolism reviews vol. 48 (2016): 4. doi: https://doi.org/10.1080/03602532.2016.1191842
About ISSX. Drug Metab Rev. 2016 Jul;48:4. doi: 10.1080/03602532.2016.1191842. PMID: 27418300.
Copy Download .nbib Format: NLM
20th North American ISSX Meeting.

Drug metabolism reviews

[No authors listed]
PMID: 27418303
Drug Metab Rev. 2016 Jul;48:21-7. doi: 10.1080/03602532.2016.1191844.

No abstract available.

Cite
20th North American ISSX Meeting. Drug Metab Rev. 2016;48:21-7doi: 10.1080/03602532.2016.1191844.
(2016). 20th North American ISSX Meeting. Drug metabolism reviews, 4821-7. https://doi.org/10.1080/03602532.2016.1191844
"20th North American ISSX Meeting." Drug metabolism reviews vol. 48 (2016): 21-7. doi: https://doi.org/10.1080/03602532.2016.1191844
20th North American ISSX Meeting. Drug Metab Rev. 2016 Jul;48:21-7. doi: 10.1080/03602532.2016.1191844. PMID: 27418303.
Copy Download .nbib Format: NLM
The relationship between .

Drug metabolism reviews

Liu D, Yu Q, Ning Q, Liu Z, Song J.
PMID: 34807779
Drug Metab Rev. 2021 Nov 22;1-21. doi: 10.1080/03602532.2021.2001493. Epub 2021 Nov 22.

UDP-glucuronyltransferase 1A1 (UGT1A1) is a member of the Phase II metabolic enzyme family and the only enzyme that can metabolize detoxified bilirubin. Inactivation and very low activity of UGT1A1 in the liver can be fatal or lead to lifelong...

Cite
Liu D, Yu Q, Ning Q, et al. The relationship between . Drug Metab Rev. 2021;1-21doi: 10.1080/03602532.2021.2001493.
Liu, D., Yu, Q., Ning, Q., Liu, Z., & Song, J. (2021). The relationship between . Drug metabolism reviews, 1-21. https://doi.org/10.1080/03602532.2021.2001493
Liu, Dan, et al. "The relationship between ." Drug metabolism reviews vol. (2021): 1-21. doi: https://doi.org/10.1080/03602532.2021.2001493
Liu D, Yu Q, Ning Q, Liu Z, Song J. The relationship between . Drug Metab Rev. 2021 Nov 22;1-21. doi: 10.1080/03602532.2021.2001493. Epub 2021 Nov 22. PMID: 34807779.
Copy Download .nbib Format: NLM
CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation.

Drug metabolism reviews

Barrangou-Poueys-Darlas M, Guerlais M, Laforgue EJ, Bellouard R, Istvan M, Chauvin P, Guillet JY, Jolliet P, Gregoire M, Victorri-Vigneau C.
PMID: 33325257
Drug Metab Rev. 2021 Feb;53(1):30-44. doi: 10.1080/03602532.2020.1859528. Epub 2021 Jan 04.

Smoking cessation is underestimated in terms of drug interactions. Abrupt smoking cessation is common in cases of emergency hospitalization and restrictions of movement. Tobacco is a known cytochrome P450 1A2 (CYP1A2) inducer, its consumption and withdrawal can lead to...

Cite
Barrangou-Poueys-Darlas M, Guerlais M, Laforgue EJ, et al. CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation. Drug Metab Rev. 2021;53(1):30-44doi: 10.1080/03602532.2020.1859528.
Barrangou-Poueys-Darlas, M., Guerlais, M., Laforgue, E. J., Bellouard, R., Istvan, M., Chauvin, P., Guillet, J. Y., Jolliet, P., Gregoire, M., & Victorri-Vigneau, C. (2021). CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation. Drug metabolism reviews, 53(1), 30-44. https://doi.org/10.1080/03602532.2020.1859528
Barrangou-Poueys-Darlas, Malcolm, et al. "CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation." Drug metabolism reviews vol. 53,1 (2021): 30-44. doi: https://doi.org/10.1080/03602532.2020.1859528
Barrangou-Poueys-Darlas M, Guerlais M, Laforgue EJ, Bellouard R, Istvan M, Chauvin P, Guillet JY, Jolliet P, Gregoire M, Victorri-Vigneau C. CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation. Drug Metab Rev. 2021 Feb;53(1):30-44. doi: 10.1080/03602532.2020.1859528. Epub 2021 Jan 04. PMID: 33325257.
Copy Download .nbib Format: NLM
Recent advances in computational metabolite structure predictions and altered metabolic pathways assessment to inform drug development processes.

Drug metabolism reviews

Schleiff MA, Dhaware D, Sodhi JK.
PMID: 33840322
Drug Metab Rev. 2021 May;53(2):173-187. doi: 10.1080/03602532.2021.1910292. Epub 2021 May 11.

Many drug candidates fail during preclinical and clinical trials due to variable or unexpected metabolism which may lead to variability in drug efficacy or adverse drug reactions. The drug metabolism field aims to address this important issue from many...

Cite
Schleiff MA, Dhaware D, Sodhi JK. Recent advances in computational metabolite structure predictions and altered metabolic pathways assessment to inform drug development processes. Drug Metab Rev. 2021;53(2):173-187doi: 10.1080/03602532.2021.1910292.
Schleiff, M. A., Dhaware, D., & Sodhi, J. K. (2021). Recent advances in computational metabolite structure predictions and altered metabolic pathways assessment to inform drug development processes. Drug metabolism reviews, 53(2), 173-187. https://doi.org/10.1080/03602532.2021.1910292
Schleiff, Mary Alexandra, et al. "Recent advances in computational metabolite structure predictions and altered metabolic pathways assessment to inform drug development processes." Drug metabolism reviews vol. 53,2 (2021): 173-187. doi: https://doi.org/10.1080/03602532.2021.1910292
Schleiff MA, Dhaware D, Sodhi JK. Recent advances in computational metabolite structure predictions and altered metabolic pathways assessment to inform drug development processes. Drug Metab Rev. 2021 May;53(2):173-187. doi: 10.1080/03602532.2021.1910292. Epub 2021 May 11. PMID: 33840322.
Copy Download .nbib Format: NLM
Showing 1357 to 56 of 56 entries